| Dr Erica Lynn Lehman, MD | |
|
9001 Wilshire Blvd Ste 308, Beverly Hills, CA 90211 | |
| (310) 867-9107 | |
| (310) 919-1199 |
| Full Name | Dr Erica Lynn Lehman |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 9001 Wilshire Blvd Ste 308, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558671750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | G61209 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erica Lynn Lehman, MD 9001 Wilshire Blvd Ste 308, Beverly Hills, CA 90211-1841 Ph: (310) 867-9107 | Dr Erica Lynn Lehman, MD 9001 Wilshire Blvd Ste 308, Beverly Hills, CA 90211 Ph: (310) 867-9107 |
News Archive
Reliv International, Inc. introduced three new products to its Relivables line at the company's national conference here today. The products represent the first extension of the Relivables line since it was introduced last August.
Children born very preterm are at increased risk for psychiatric disorders in early childhood, study results suggest.
Covidien, a leading global provider of healthcare products, has introduced PENNSAID (diclofenac sodium topical solution) 1.5% w/w to the U.S. market. PENNSAID is the only FDA-approved topical non-steroidal anti-inflammatory drug in a vehicle solution containing dimethyl sulfoxide, a known penetrating agent. It is indicated for treatment of the signs and symptoms of osteoarthritis of the knee(s).
To better understand the organization of the brain and the perceptual tendencies in humans, a team of four scientists are recording video from four head-mounted cameras - with eyetracking and head movement - and assembling a massive video database with more than 240 hours of first-person video that can be used by researchers everywhere.
Electromed, Inc., which is a leader in developing innovative airway clearance therapy products for use by patients with compromised pulmonary function, today announced pricing of its initial public offering of 1,700,000 shares of common stock at a price of $4.00 per share, before underwriting discounts and commissions.
› Verified 7 days ago
Dr. Joseph Sidikaro, M.D., PH. D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 435 N Roxbury Dr Ste 410, Beverly Hills, CA 90210 Phone: 310-858-6569 Fax: 310-858-3922 | |
Dr. Lisa H Dang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 250 N Robertson Blvd Ste 102, Beverly Hills, CA 90211 Phone: 310-385-3540 Fax: 310-385-3521 | |
Ivan Richard Jacobs, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8501 Wilshire Blvd, Ste 316, Beverly Hills, CA 90211 Phone: 310-652-2255 Fax: 310-652-2039 | |
Dr. Laura Eve Fox, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 416 N Bedford Dr, #300, Beverly Hills, CA 90210 Phone: 310-273-2333 Fax: 310-273-6583 | |
Dr. Raymond S Douglas, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9675 Brighton Way Ste 410, Beverly Hills, CA 90210 Phone: 310-363-8757 Fax: 310-363-8758 | |
Dr. Aaron Savar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 433 N Camden Dr, Suite 1150, Beverly Hills, CA 90210 Phone: 310-276-9800 | |
Dr. Mehryar Ray Taban, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9735 Wilshire Blvd., Suite 204, Beverly Hills, CA 90212 Phone: 310-278-1836 Fax: 310-278-1828 |